232: Prenatally diagnosed congenital diaphragmatic hernia: How can microarray inform prognosis? - 19/12/14
Doi : 10.1016/j.ajog.2014.10.278
Teresa Sparks 2, Jody Farrell 5, Kristen Gosnell 5, Rachael Overcash 3, Stephen Shew 6, Veronique Tache 4, Deborah Wing 1, Erica Wu 1, Mary Norton 2
1 University of California, Irvine, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Irvine, CA
2 University of California, San Francisco, Division of Maternal-Fetal Medicine, Obstetrics & Gynecology, Pediatrics-Genetics, San Francisco, CA
3 University of California, San Diego, Division of Maternal-Fetal Medicine, Department of Reproductive Medicine, San Diego, CA
4 University of California, Davis, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sacramento, CA
5 University of California, San Francisco, Fetal Treatment Center, San Francisco, CA
6 University of California, Los Angeles, Department of Pediatric Surgery, Los Angeles, CA
Le texte complet de cet article est disponible en PDF.
Plan
© 2015
Publié par Elsevier Masson SAS.
Vol 212 - N° 1S
P. S128-S129 - janvier 2015 Retour au numéro
Article précédent
- 231: Utilization of 4 and 8 hr urine collections compared to spot urine protein/creatinine (P/C) ratio and 24 hr urine protein collections for diagnosis of preeclampsia
- Tamera Hatfield, Megan Stephenson, Judith Chung, Deborah Wing
- 233: Cannabis in pregnancy: legal, but safe?
- Teresa Worstell, Margaret Gorman, Aaron Caughey
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?